Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
49 participants
OBSERVATIONAL
2020-03-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the present study is to analyze miRNAs associated with SARS-CoV-2 infection, disease severity and mortality.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers of LONG COVID (LONG COVID_LCM)
NCT05672602
Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL
NCT04807699
MicroRNA Regulation of Chronic Inflammation During Aging
NCT05392582
Dynamic Monitoring of Circulating microRNA Changes in Patients With or Without Multiple Organ Failure
NCT03059524
DYNamic Assessment of Multi Organ Level Dysfunction in Patients Recovering From Covid-19
NCT05060497
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mild Respiratory Failure Covid-19
Patients with Covid-19 and mild respiratory failure defined as PaO2/FiO2 201-300 mm Hg
mi-RNA analysis
To identify biomarkers that could predict the risk of a worsened COVID-19 disease progression.
Severe Respiratory Failure Covid-19
Patients with Covid-19 and severe respiratory failure defined as PaO2/FiO2 ≤100 mm Hg.
mi-RNA analysis
To identify biomarkers that could predict the risk of a worsened COVID-19 disease progression.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mi-RNA analysis
To identify biomarkers that could predict the risk of a worsened COVID-19 disease progression.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of SARS-CoV-2 infection confirmed by molecular testing on nasopharyngeal swabs
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
TINELLI GIOVANNI
Associate Professor of Vascular Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, RM, Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3155
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.